Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IDI2 antisense RNA 1 (IDI2-AS1) is a long non-coding RNA (lncRNA) gene located on human chromosome 10, distinct from protein-coding regions, and does not encode a protein[1][4]. Its transcript is thought to regulate the neighboring sense-strand gene IDI2 at the post-transcriptional level, but its precise functional role is largely uncharacterized[2][4]. Experimental studies demonstrate that IDI2-AS1 responds rapidly to simulated viral infection (Poly I:C stimulation), with significant downregulation during this cellular stress condition, suggesting possible involvement in immune or stress responses[3]. However, experimental evidence for direct disease association, drug targeting, or precise biological mechanism remains currently limited. IDI2-AS1 is considered a regulatory lncRNA, potentially functioning as a sensor or modulator in host cell stress pathways, but further research is required to clarify its role and molecular interactions[1][3][4].
none known (as no targeting drugs are identified or described)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IDI2 antisense RNA 1 (IDI2-AS1).